Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00156585
Status:
COMPLETED
Last Update Posted:
2015-01-15
First Post:
2005-09-07
Brief Title:
Predictive Value of Dynamic Contrast Enhancement MRI on a Cerebral Tumor Response to Gamma Knife Treatment
Sponsor:
Martin Lepage
Organization:
Université de Sherbrooke
Study Overview
Official Title:
Prospective Study of Predictive Value of Dynamic Contrast Enhancement Magnetic Resonance Imaging With Gadolinium on the Response of a Cerebral Tumor to a Treatment With Gamma Knife
Status:
COMPLETED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypothesis the pattern of MRI contrast enhancement after gadolinium injection is different in tumors that respond well to gamma knife
We are going to acquire sequential T1-weighted images of brain lesions before during and after injection of Gd-DTPA This will be repeated before and after a treatment with gamma knife We will then analyse our results to see if there are common enhancement characteristics between lesions that will respond well to the radiosurgery treatment Response will be clinically assessed by tumor volume as determined by MRI approximately 4 to 6 months after treatment
We are going to acquire sequential T1-weighted images of brain lesions before during and after injection of Gd-DTPA This will be repeated before and after a treatment with gamma knife We will then analyse our results to see if there are common enhancement characteristics between lesions that will respond well to the radiosurgery treatment Response will be clinically assessed by tumor volume as determined by MRI approximately 4 to 6 months after treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None